Startup TeselaGen Biotechnology is preparing to launch a cloud-based commercial version of the j5 software package, an automated DNA cloning tool that was developed by a research team at the Joint BioEnergy Institute.

TeselaGen licensed j5 from Lawrence Berkeley National Laboratory, the lead institutional partner of JBEI. The commercial version of the software is currently being tested in an ongoing private beta by several undisclosed industrial and pharmaceutical companies ahead of a full launch slated for early 2013.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.